• LOGIN
Repository logo

BORIS Portal

Bern Open Repository and Information System

  • Publication
  • Projects
  • Funding
  • Research Data
  • Organizations
  • Researchers
  • LOGIN
Repository logo
Unibern.ch
  1. Home
  2. Publications
  3. Drug survival of dupilumab, tralokinumab and upadacitinib in patients with atopic dermatitis: An international, real-world comparative study.
 

Drug survival of dupilumab, tralokinumab and upadacitinib in patients with atopic dermatitis: An international, real-world comparative study.

Options
  • Details
BORIS DOI
10.48620/85500
Date of Publication
February 6, 2025
Publication Type
Article
Division/Institute

Clinic of Dermatology...

Author
Torres, Tiago
Yeung, Jensen
Prajapati, Vimal
Ribero, Simone
Balato, Anna
Valerio Marzano, Angelo
Cruz, Maria João
Paiva Lopes, Maria João
Lazaridou, Elizabeth
Carrascosa, Jose-Manuel
Alvarenga, José Miguel
Farinha, Pedro
Duarte, Bruno
Sood, Siddhartha
Rankin, Brian D
Ortoncelli, Michela
Caccavale, Stefano
Ferrucci, Silvia Mariel
Rosa, Gilberto Pires
Daponte, Athina Ioanna
Silvi, Gianmarco
Peris, Ketty
Gori, Niccolò
Herranz, Pedro
Prignano, Francesca
Kolios, Antonio
Clinic of Dermatology
Rompoti, Natalia
Gkalpakiotis, Spyridon
Chiricozzi, Andrea
Subject(s)

600 - Technology::610...

Series
Journal of the European Academy of Dermatology and Venereology
ISSN or ISBN (if monograph)
1468-3083
0926-9959
Publisher
Wiley
Language
English
Publisher DOI
10.1111/jdv.20581
PubMed ID
39912554
Handle
https://boris-portal.unibe.ch/handle/20.500.12422/205107
Show full item
File(s)
FileFile TypeFormatSizeLicensePublisher/Copright statementContent
Acad Dermatol Venereol - 2025 - Torres - Drug survival of dupilumab tralokinumab and upadacitinib in patients with atopic.pdftextAdobe PDF286.67 KBpublished
BORIS Portal
Bern Open Repository and Information System
Build: d1c7f7 [27.06. 13:56]
Explore
  • Projects
  • Funding
  • Publications
  • Research Data
  • Organizations
  • Researchers
More
  • About BORIS Portal
  • Send Feedback
  • Cookie settings
  • Service Policy
Follow us on
  • Mastodon
  • YouTube
  • LinkedIn
UniBe logo